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Enterovesical ﬁstulas are a well-known complication of inﬂammatory and malignant bowel disease.
Bladder carcinoma, however, is an extremely rare etiology. We describe a case of squamous cell carcinoma
of the bladder with an enterovesical ﬁstula. This rare phenomenon has never been previously reported in
western literature. We review the diagnosis, work up and treatment of enterovesical ﬁstulas. Unfortu-
nately, the prognosis for these highly invasive tumors is very poor and the treatment is often palliative. The
high morbidity and mortality makes management of these patients exceptionally challenging.
 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Enterovesical ﬁstulas are a well-known complication of
inﬂammatory and malignant bowel disease. Bladder carcinoma,
however, is an extremely rare etiology and ﬁstulas secondary to
primary squamous cell carcinoma of the bladder are even rarer. To
our knowledge there are no previously reported cases in western
literature, with only one prior case reported out of Taiwan. Below
we describe a case of chronic diarrhea in the setting of antibiotic
resistant urinary tract infections caused by squamous cell carci-
noma of the bladder with an enterovesical ﬁstula.Case presentation
A 61 year old Caucasian female presented to outpatient urologist
ofﬁce with recurrent antibiotic resistant urinary tract infections.
The patient underwent cystoscopy which revealed a necrotic
bladder mass. She was scheduled for resection of the mass, but the
procedure was canceled due to uncontrollable diarrhea. She had a
colonoscopy which was negative for any abnormalities. Her
symptoms persisted over the next 2 months until she was admitted
to the hospital with hematochezia, new onset atrial ﬁbrillation,
anemia, leukocytosis, metabolic acidosis and urosepsis.
A CT of the abdomen revealed mild diffuse bladder wall thick-
ening and a 3.7  5.2  8.4 cm intraluminal neoplastic bladder).
Inc. This is an open access article umass. There was oral contrast seen entering the urinary bladder, as
well as, large amount of gas consistent with an enterovesical ﬁstula.
A foley catheter was placed and feculent material was noted to be
draining from the bladder. The patient was taken to the operating
room exploratory laparotomy, enterolysis, and takedown of enter-
ovesical ﬁstula. She was found to have a large tumor mass
emanating from the bladder extending into the pelvic sidewall, the
small bowel and the serosa of the sigmoid colon.
Pathological examination revealed inﬁltrating squamous cell
carcinoma arising from the bladder with overlying urothelial
epithelial dysplasia. The tumor extensively inﬁltrated the bladder
wall from lamina propria to the full thickness of the muscularis
propria, the perivesicular adipose tissue, through the serosal aspect
of the bowel wall and involving the full thickness of the resected
small bowel wall. Lymph nodes and margins were negative for
tumor. Post-operatively the patient did well. She had return of
normal bowel and bladder function. She was discharged on postop
day 7 and had a normal cystogram on postop day 11 (Figs. 1e3).Discussion
First described in1888byWHCripps, Enterovesicalﬁstulas are an
abnormal connection between the epithelialize surface of the bowel
and the bladder. They are responsible for 2e3 patients per 10,000
admissions, 1 out of every 3000 surgical admissions, and carry an
annual incidence of 0.5 per 100,000. The most common causes
overall are inﬂammatory (52%), neoplastic (35%), and traumatic
(16%). Among the neoplastic causes, primary urologic carcinomas
account for 16% of cases and gastrointestinal carcinomas make upnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. CT scan of ﬁstula with oral contrast passing into bladder.
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carcinomas.1
Greater than 90% of malignant tumors of the bladder are uro-
thelial cell carcinoma. Squamous cell carcinoma is the second most
commonmalignant tumor of the bladder, but accounts for just 5% in
industrialized nations. The incidence is far greater in areas where
Schistosoma haematobium in endemic, such as Africa and theMiddle
East where it accounts for up to 50e75% of cases. The infrequency of
squamous cell carcinoma in the US when compounded by the rarity
of enterovesical ﬁstulas arising from primary bladder carcinomas
(16%), make this case presentation particularly unique.2 Indeed
there are no previously reported cases of enterovesical ﬁstula
secondary to squamous cell carcinoma in western literature.
Though initially the cause of our patient’s symptomatology was
unclear, her clinical presentation was very typical. Patient’s most
commonly present with urinary tract infection, pneumaturia,
fecaluria and hematuria. They may present with the classicFigure 2. Low power (4) SCC invades bowel wall of small intestine.Gouverneur syndrome e a constellation of symptoms including
suprapubic pain, frequency, dysuria, and tenesmus. Our patient’s
history of recurrent urinary tract infections resistant to antibiotics is
also classically seen. While fecaluria is pathognomonic for the
presence of a ﬁstula, pneumaturia can also be caused by gas-
producing organism in bladder. Though the patient in this case
presented with chronic diarrhea due to her ﬁstula, in the majority
of cases ﬂuid ﬂows from the bowel to the bladder. The rate of rectal
micturition is only 19%.3
Most commonly, the diagnosis of an enterovesical ﬁstula is
made on a clinical basis, but the work up and conﬁrmation of the
diagnosis can be difﬁcult. Though there are a variety of different
diagnostic modalities, there is no consensus on a diagnostic algo-
rithm and no clear gold standard study exists. Useful diagnostic
studies include CT scan, MRI, cystoscopy, barium enema, poppy
seed test and colonoscopy. CT scan may demonstrate air or contrast
within the bladder, thickening of the bladder wall, or anFigure 3. High power (40) typical morphology of squamous cell carcinoma.
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mately, the most deﬁnitive test is exploratory laparotomy.
No deﬁnitive study exists of the treatment outcomes for enter-
ovesical ﬁstula due to carcinoma. This diagnosis conﬁrms a very
poor prognosis. All these tumors are T4 by deﬁnition due to
extravesical spread and there is a >85% 2 year mortality rate if left
untreated.5 Squamous cell carcinoma of the bladder has been
shown to have a worse prognosis due to a locally advanced stage at
the time of presentation. Surgical treatment for these patients is,
therefore, often palliative. The symptomatology can be so devas-
tating that a consensus exists to offer palliative surgical treatment
unless the patient is terminally ill. The reported morbidity and
mortality for any surgical intervention for advanced neoplastic
disease remains very high and prognosis remains dismal.5 In much
of the surgical literature, successful surgery is deﬁned as greater
than 60 days survival following any procedure.
Conclusion
Enterovesical ﬁstula secondary to squamous cell carcinoma of
the bladder is an extremely rare phenomenon. It is our belief thatthe above report is the ﬁrst in western literature. Enterovesical
ﬁstula due to any bladder carcinoma can be severely debilitating to
the patient. Unfortunately, even palliative treatment has a signiﬁ-
cant rate of morbidity and mortality making this disease incredibly
difﬁcult for both patient and provider.Conﬂict of interest
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